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Necrosis is often viewed as an accidental and unregulated cellular event. However, accumulating 
evidence suggests that necrosis, like apoptosis, can be executed by regulated mechanisms. Hitomi 
et al. (2008) now describe an extensive network of genes that mediate a form of programmed 
necrosis called necroptosis.On the basis of genetic analysis in the 
nematode Caenorhabditis elegans, it has 
been postulated that developmental and 
homeostatic programmed cell death, 
as it occurs in higher animals, is usu-
ally mediated by apoptosis. Apoptosis is 
defined by an ensemble of morphologi-
cal features, including chromatin con-
densation and nuclear fragmentation, 
cell shrinkage, plasma membrane bleb-
bing, and formation of apoptotic bod-
ies. In contrast, necrosis fails to display 
a stereotyped morphology (except for 
the early rupture of plasma membranes) 
and has historically been regarded as an 
unregulated means of cell death that is 
induced by nonspecific and nonphysi-
ological stress (Kroemer et al., 2008). 
Defying this view, Hitomi et al. (2008) now 
report the existence of a complex molec-
ular pathway mediating programmed 
necrosis that they have unraveled using 
a systems biology approach.
Multiple lines of evidence indicate 
that necrosis can be a programmed 
event, both in its occurrence and in its 
mechanism: (1) cell death with a necrotic 
appearance can contribute to embryonic 
development and adult tissue homeosta-
sis, (2) necrotic cell death can be induced 
by ligands that bind to specific plasma 
membrane receptors, and (3) necrosis 
can be regulated by genetic, epigenetic, 
and pharmacological factors (Golstein 
and Kroemer, 2007). Moreover, the inac-
tivation of caspases causes a shift from 
apoptosis either to cell death morpholo-
gies with mixed necrotic and apoptotic 
features or to full-blown necrosis (Kroe-
mer et al., 2008). This proves that differ-ent cell death modalities crossregulate 
each other and substantiates the notion 
that necrosis may constitute a default 
cell death pathway that is unmasked 
when essential effectors of apoptosis are 
inhibited (Golstein and Kroemer, 2007).
Recently, the term necroptosis has 
been used to designate one particu-
lar type of programmed necrosis that 
depends on the serine/threonine kinase 
activity of RIP1 (Kroemer et al., 2008). 
Indeed, RIP1 represents the molecular 
target of a new class of cytoprotective 
agents, the necrostatins (Degterev et al., 
2005). In their current work, Hitomi et al. 
(2008) apply systems biology to study two 
specific cases of necroptosis—namely, 
the necrotic demise of L929 mouse fib-
rosarcoma cells induced either by liga-
tion of the tumor necrosis factor (TNF) 
receptor or by caspase inhibition with 
Z-VAD.fmk [Z-Val-Ala-Asp(OMe).fluorom-
ethylketone]. These responses were then 
compared with classical apoptosis in 
NIH 3T3 murine fibroblasts, as triggered 
by TNF receptor ligation. Genome-wide 
screens using small interfering RNAs 
(siRNAs) combined with multiple in silico 
analyses delineated a cellular signal-
ing network that regulates necroptosis 
and the molecular bifurcation between 
necroptosis and apoptosis.
The morphological uniformity of 
apoptosis hides a heterogeneous array 
of lethal processes that differ in their 
molecular determinants and functional 
impact, leading for instance to the dis-
tinction between intrinsic (mitochondrial) 
and extrinsic (death receptor-mediated) 
apoptotic pathways (Kroemer et al., Cell 135, De2008). Hence, an important problem is 
whether necrosis is the manifestation 
of a uniform process or of a collection 
of cell death subroutines. The pharma-
cological or genetic inhibition of several 
key enzymes has been shown to deeply 
affect the execution of programmed 
necrosis (Figure 1). These include RIP1, 
cyclophilin D, poly(ADP-ribose) poly-
merase 1 (PARP-1), and apoptosis-
inducing factor (AIF). RIP1 kinase activ-
ity is required for death receptor- and 
Z-VAD.fmk-mediated necroptosis in 
both murine and human cells (Holler et 
al., 2000), and necrostatins confer in 
vivo neuroprotection against ischemia, 
a condition that elevates necrotic stimuli 
such as reactive oxygen species and 
Ca2+ overload (Degterev et al., 2005). 
Mice lacking cyclophilin D (a mitochon-
drial peptidylprolyl cis-trans isomerase 
that contributes to the so-called perme-
ability transition pore complex [PTPC]) 
are substantially more resistant to car-
diac and cerebral ischemic injury than 
their wild-type littermates (Nakagawa 
et al., 2005). Excessive activation of the 
DNA repair protein PARP-1 has been 
implicated in necrosis triggered by alky-
lating DNA damage (Zong et al., 2004). 
In rodent models of ischemia, neuropro-
tective effects are exerted by genetic 
inhibition of calpains (which are Ca2+-
activated proteases) and of the caspase-
independent death effector AIF (Golstein 
and Kroemer, 2007).
Some evidence suggests that these 
elements are deeply interconnected. 
RIP1 can promote the PTPC-dependent 
mitochondrial permeability transition cember 26, 2008 ©2008 Elsevier Inc. 1161
(which is also triggered by reactive oxy-
gen species and Ca2+) by inducing the 
accumulation of pronecrotic ceramides 
or by binding to another PTPC compo-
nent, the adenine nucleotide translocase 
(Golstein and Kroemer, 2007). Moreover, 
Ca2+-activated calpains favor the release 
of AIF from mitochondria, as well as the 
spillage of lysosomal cathepsins into the 
cytosol (Golstein and Kroemer, 2007). 
PARP-1 activation stimulates the mito-
chondrial release of AIF, and AIF-medi-
ated DNA degradation further activates 
PARP-1 (Yu et al., 2002), thereby engag-
ing a vicious cycle. The implication of 
PARP proteins in programmed necrosis 
is further substantiated by the findings of 
Hitomi et al. (2008), which reveal PARP-2 
as one of the core regulators of necrop-
tosis.
Mitochondrial membrane permeabili-
zation contributes to cell death and can 
either derive from the mitochondrial per-
meability transition (which first affects 
the mitochondrial inner membrane) or 
from mitochondrial outer membrane per-
meabilization, which is mediated by Bax 
or Bak, two proapoptotic members of 
the Bcl-2 protein family (Kroemer et al., 
2007). Reportedly, L929 cells undergo-
ing necroptosis do not exhibit mitochon-
drial outer membrane permeabilization 
(Golstein and Kroemer, 2007). Moreover, 
the knockout of ppif (the gene coding 
for cyclophilin D) in mice fails to prevent 
apoptosis that is dependent on permea-
bilization of the mitochondrial outer mem-
brane (Nakagawa et al., 2005). None-
theless, necroptosis is linked to rapid 
mitochondrial dysfunction that leads 
to the excessive production of reactive 
oxygen species. Thus, it remains for-
mally possible that a sudden breakdown 
of mitochondrial function (which causes 
a drop in intracellular ATP), perhaps sus-
tained by excessive activation of PARP 
proteins (which causes the depletion of 
NAD+), might account for the bioener-
getic crisis that constitutes the final step 
of programmed necrosis.
Surprisingly, Hitomi et al. identified the 
BH3-only protein Bmf as a component 
of the core machinery for necroptosis. 
In healthy cells, Bmf is sequestered to 
cytoskeletal structures by virtue of its 
interaction with dynein light chain 2. 
Under conditions of cellular distress, the 
release of Bmf from this dock facilitates 1162 Cell 135, December 26, 2008 ©2008 ElsFigure 1. The Interface between Apoptosis and Programmed Necrosis
The programmed necrosis pathway studied by Hitomi et al., termed necroptosis, centers on the activa-
tion of the serine/threonine kinase RIP1 (receptor-interacting protein kinase 1), which can be triggered in 
L929 murine fibrosarcoma cells by ligation of the tumor necrosis factor receptor (TNFR) or inhibition of 
caspases. In NIH 3T3 murine fibroblasts, TNFR activation ignites the extrinsic apoptotic pathway, which 
depends on caspase-8. Caspase-8-mediated degradation of RIP1 may represent one of the major mo-
lecular switches between apoptosis and necroptosis. Apoptosis and necroptosis may preferentially in-
volve mitochondrial outer membrane permeabilization (MOMP) and the mitochondrial permeability transi-
tion (MPT), respectively. The figure has been assembled from the data reported by Hitomi et al. (2008) in 
this issue, as well as from previous publications on programmed necrosis. For the sake of clarity, multiple 
intermediate regulators of apoptosis have not been depicted. Abbreviations: AIF, apoptosis-inducing fac-
tor; ANT, adenine nucleotide translocase; Cyt c, cytochrome c; GPI, glycosylphosphatidylinositol; IFN, in-
terferon; LMP, lysosomal membrane permeabilization; PTPC, permeability transition pore complex; ROS, 
reactive oxygen species; TLR, Toll-like receptor; TNFα, tumor necrosis factor α; TNFR, tumor necrosis 
factor receptor; Z-VAD.fmk, Z-Val-Ala-Asp(OMe).fluoromethylketone.its interaction with (and inhibition of) the 
antiapoptotic proteins Bcl-2 and Bcl-
XL (Puthalakath et al., 2001). The exact 
molecular mechanisms by which Bmf 
promotes apoptosis versus necropto-
sis remain to be clarified. Antiapoptotic 
Bcl-2 proteins can suppress both apop-
tosis and necrosis, and inhibit both mito-
chondrial outer membrane permeabiliza-
tion (by sequestering Bax and Bak) and 
the mitochondrial permeability transition 
(through their interaction with the PTPC) evier Inc.(Golstein and Kroemer, 2007; Kroemer et 
al., 2007). Thus, it is tempting to specu-
late that Bmf (and maybe other BH3-only 
proteins) might promote apoptosis by 
relieving Bcl-2/Bcl-XL-mediated inhibition 
of mitochondrial outer membrane per-
meabilization, and necrosis by interfering 
with the Bcl-2/Bcl-XL-mediated blockage 
of the mitochondrial permeability transi-
tion (Figure 1). Hitomi et al. (2008) failed 
to identify cyclophilin D (or any other 
protein from the PTPC) in their screen for 
genes involved in necroptosis. Whether 
this is due to methodological limitations 
or rather hints at a hitherto unsuspected 
mechanism of Bmf-dependent cell death 
remains to be established.
The challenge of characterizing the 
precise mechanisms of programmed 
necrosis, as well as of the molecular 
switches between apoptosis and necro-
sis, has major therapeutic implications. 
In some instances, the selective inhibi-
tion of necrosis (and/or the facilitation of 
apoptotic cell death) may limit inflamma-
tion, and hence reduce secondary tissue 
damage. Conversely, it may be desirable 
to trigger the necrotic death of cancer 
cells that are resistant to apoptosis. 
Necrostatins have proved their therapeu-
tic potential in a murine model of stroke 
(Degterev et al., 2005). Similarly, phar-
macological and/or genetic inhibition 
of cyclophilin D, AIF, PARP-1, calpains, 
and cathepsins afford cytoprotection in 
vivo in several models of acute cell loss 
(Golstein and Kroemer, 2007). Only the Membrane fission and membrane fusion 
are the two processes fundamental to 
membrane trafficking. Membrane fission 
is the process by which a bud separates 
from a lipid membrane. The best-studied 
fission protein is the GTPase dynamin 
(Praefcke and McMahon, 2004), which 
forms “collar” structures at the neck of 
nascent buds (Takei et al., 1995) and 
can spontaneously polymerize into heli-
cal polymers in the presence or absence 
of membranes (Sweitzer and Hinshaw, 
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During membrane fission, the GT
buds. Although it has been propo
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helix disassembly is also necessfuture will tell which among the hits iden-
tified by Hitomi et al. will serve as new 
targets for the therapeutic manipulation 
of programmed necrosis. Indeed, sev-
eral of the necroptosis-relevant proteins 
identified, including proteins belonging 
to the interferon and Toll-like receptor 
signaling systems, have already been 
accused of mediating pathological cell 
death in vivo.
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(Roux et al., 2006; Lenz et al., 2008). 
These theories suggest that because 
dynamin is a right-handed helix, further 
right-handed twisting would induce con-
striction. In this issue, Bashkirov et al. 
(2008) and Pucadyil and Schmid (2008) 
now propose a different mechanism for 
fission whereby depolymerization of 
the dynamin helix after GTP hydrolysis 
enables bud separation. In this model, 
the dynamin helix, having brought the 
lipids in the neck region of the bud into 
ne Fission
S, 06560 Valbonne, France
mblies at the neck of membrane 
onstriction of the dynamin helix, 
2008) unexpectedly shows that 
